Driving groundbreaking research. Improving lives.
Helping people with an MPN live a better quality of life as we work toward answers to prevention, progression and a cure for polycythemia vera (PV), essential thrombocythemia (ET), and myelofibrosis (MF) – blood cancers collectively known as myeloproliferative neoplasms.
What is Primary Myelofibrosis (MF)?
Primary Myelofibrosis (MF)
PMF is a chronic blood cancer in which excessive scar tissue forms in the bone marrow and impairs its ability to produce normal blood cells.
What is Essential Thrombocythemia (ET)?
Essential Thrombocythemia (ET)
Most commonly diagnosed in women over the age of 50, ET is associated with a proliferation of platelet precursors in the bone marrow and complications frequently include blood clotting and/or bleeding.
What is Polycythemia Vera (PV)?
Polycythemia Vera (PV)
The disease is most common in men over the age of 60, but anyone can develop PV. PV patients typically experience an elevated red blood cell count, an elevated platelet count and an enlarged spleen, especially over time.
Recent News
Need help with MPN related out-of-pocket expenses?
MPN NEWS | June 25, 2024
Need help with MPN related out of pocket expenses? The PAN Foundation is helping patients with Philadelphia chromosome negative myeloproliferative neoplasms (MPN) afford their out-of-pocket costs. If you’re a patient or caregiver looking for resources to help with your treatment-related costs, we encourage you to learn more about the PAN Foundation and its $3,250 annual… Read More »Need help with MPN related out-of-pocket expenses?
MPN patient guidelines updated by NCCN
MPN NEWS | June 24, 2024
To stay up to date on everything MPNs, patients and their families and caregivers have access to a just updated resource that includes 75 pages of plain language questions, answers, and explanations written specifically for people affected by MPNs. The comprehensive document is based on current clinical practice guidelines created by national leaders in the… Read More »MPN patient guidelines updated by NCCN
Vikas Gupta, MD, FRCP, FRCPPath
MPN NEWS | June 24, 2024
Profile: Vikas Gupta, MD, FRCP, FRCPPath Princess Margaret Cancer Centre University Health Network, Toronto, Canada How can we best study transplant vs best available non-transplant therapies in myelofibrosis patients? According to Dr. Vikas Gupta, studies have shown that high-risk myelofibrosis (MF) patients appear to have better survival with hematopoietic stem cell transplants (HCT) than with… Read More »Vikas Gupta, MD, FRCP, FRCPPath
![](https://mpnresearchfoundation.org/wp-content/uploads/2021/03/Julie-Libon-MPN-Patient-Story-small-1.jpg)
Ready to do more?
Julie and her family joined team MPN and created HikeMF to join the fight against MPNs.
Stay Connected
![](https://mpnresearchfoundation.org/wp-content/uploads/2021/03/MPN_Blood_Cancer_Researcher.gif)
With an investment today, you can accelerate research for better outcomes.
By supporting MPN Research Foundation, you’re also supporting countless doctors and researchers around the world who are working to find a cure for these rare diseases.